Wednesday, June 24, 2009

Eli Lilly ‘Ghostwrote’ Articles to Market Zyprexa, Files Show

This article from Bloomberg is a good reminder about validity of peer-review data and helps to put perspective on corporate involvement in ghostwriting activities. There is a lot of buzz about this topic in the consumer media recently.

http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aVvfe.v1k_VY

No comments:

Post a Comment